Local Control and Toxicity in a Large Cohort of Central Lung Tumors Treated With Stereotactic Body Radiation Therapy

Ankit Modh1, Andreas Rimner1, Eric Williams2, Amanda Foster1, Mihir Shah1, Weiji Shi3, Zhigang Zhang3, Daphna Y. Gelblum4, Kenneth E. Rosenzweig5, Ellen D. Yorke2, Andrew Jackson2, Abraham J. Wu1
1Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
2Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York
3Department of Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York
4Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York
5Department of Radiation Oncology, Mount Sinai Medical Center, New York, New York

Tài liệu tham khảo

Fakiris, 2009, Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study, Int J Radiat Oncol Biol Phys, 75, 677, 10.1016/j.ijrobp.2008.11.042 Timmerman, 2010, Stereotactic body radiation therapy for inoperable early stage lung cancer, JAMA, 303, 1070, 10.1001/jama.2010.261 Timmerman, 2006, Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer, J Clin Oncol, 24, 4833, 10.1200/JCO.2006.07.5937 Bezjak A. Stereotactic body radiation therapy in treating patients with stage I non-small cell lung cancer. Available at: http://clinicaltrials.gov/show/NCT00750269. Last accessed August 4, 2014. Mohan, 1988, A comprehensive three-dimensional radiation treatment planning system, Int J Radiat Oncol Biol Phys, 15, 481, 10.1016/S0360-3016(98)90033-5 Chui, 1994, Dose calculation for photon beams with intensity modulation generated by dynamic jaw or multileaf collimations, Med Phys, 21, 1237, 10.1118/1.597206 Ettinger, 2013, Non-small cell lung cancer, version 2.2013, J Natl Compr Cancer Netw, 11, 645, 10.6004/jnccn.2013.0084 Wheldon, 1998, The linear-quadratic transformation of dose-volume histograms in fractionated radiotherapy, Radiother Oncol, 46, 285, 10.1016/S0167-8140(97)00162-X Farewell, 1982, The use of mixture models for the analysis of survival data with long-term survivors, Biometrics, 38, 1041, 10.2307/2529885 Schultheiss, 1986, Effect of latency on calculated complication rates, Int J Radiat Oncol Biol Phys, 12, 1861, 10.1016/0360-3016(86)90331-7 Tucker, 2010, Late rectal toxicity on RTOG 94-06: Analysis using a mixture Lyman model, Int J Radiat Oncol Biol Phys, 78, 1253, 10.1016/j.ijrobp.2010.01.069 Deasy, 2010, Improving normal tissue complication probability models: The need to adopt a “data-pooling” culture, Int J Radiat Oncol Biol Phys, 76, S151, 10.1016/j.ijrobp.2009.06.094 Jackson, 2010, The lessons of QUANTEC: Recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome, Int J Radiat Oncol Biol Phys, 76, S155, 10.1016/j.ijrobp.2009.08.074 Jackson, 2006, The atlas of complication incidence: A proposal for a new standard for reporting the results of radiotherapy protocols, Semin Radiat Oncol, 16, 260, 10.1016/j.semradonc.2006.04.009 Cox, 2012, Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery, Int J Radiat Oncol Biol Phys, 83, e661, 10.1016/j.ijrobp.2012.01.080 Oshiro, 2010, Stereotactic body radiotherapy for lung tumors at the pulmonary hilum, Strahlenther Onkol, 186, 274, 10.1007/s00066-010-2072-y Bral, 2011, Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a phase II trial, Int J Radiat Oncol Biol Phys, 80, 1343, 10.1016/j.ijrobp.2010.04.056 Onishi, 2004, Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study, Cancer, 101, 1623, 10.1002/cncr.20539 Ohri, 2012, Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: A report from the Elekta collaborative lung research group, Int J Radiat Oncol Biol Phys, 84, e379, 10.1016/j.ijrobp.2012.04.040 Rowe, 2012, Stereotactic body radiotherapy for central lung tumors, J Thorac Oncol, 7, 1394, 10.1097/JTO.0b013e3182614bf3 Senthi, 2013, Outcomes of stereotactic ablative radiotherapy for central lung tumours: A systematic review, Radiother Oncol, 106, 276, 10.1016/j.radonc.2013.01.004 Haasbeek, 2011, Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer, J Thorac Oncol, 6, 2036, 10.1097/JTO.0b013e31822e71d8 Chang, 2008, Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer, Int J Radiat Oncol Biol Phys, 72, 967, 10.1016/j.ijrobp.2008.08.001 Chen, 2012, Local extension at the hilum region is associated with worse long-term survival in stage I non-small cell lung cancers, Ann Thorac Surg, 93, 389, 10.1016/j.athoracsur.2011.09.079 Chang, 2014, Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: How to fly in a “no fly zone”, Int J Radiat Oncol Biol Phys, 88, 1120, 10.1016/j.ijrobp.2014.01.022 Barriger, 2012, A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy, Int J Radiat Oncol Biol Phys, 82, 457, 10.1016/j.ijrobp.2010.08.056